2024 Year in Review: Lilly’s total investment at LEAP climbs to $13.5B
Lilly said the expansion is expected to add 400 full-time jobs for highly skilled workers, including engineers, scientists, operations personnel and lab technicians.
Lilly said the expansion is expected to add 400 full-time jobs for highly skilled workers, including engineers, scientists, operations personnel and lab technicians.
The Indiana Economic Development Corp. inched closer to its vision for its LEAP Research and Innovation District in Lebanon this year with more than $100 million in additional state funding, steps to secure water for the site and additional private investment.
Despite tightening revenue, Republican leaders quickly dismissed any notion that 2025 could be the year Indiana ends its prohibition on marijuana.
It’s been another busy year in Indiana health care and life sciences, with headlines nearly every week announcing another billion-dollar deal or investment.
IBJ has reported extensively on numerous projects throughout this year in the core of Indianapolis and across the area—some that made significant progress and others that ground to a halt.
The state has spent more than $690 million so far establishing the LEAP Research and Innovation District. Outgoing economic leaders say the project is a huge success, but some political leaders are cautious.
The Indiana Family and Social Service Administration’s Office of Medicaid Policy and Planning estimates that 5% to 20% of eligible members would be prescribed weight-loss medications.
The findings are consistent with a statewide water study released in August that concluded Indiana has a “plentiful” but unevenly distributed water supply.
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human papillomavirus infections before cancer develops and to treat HPV cancers after detection.
Pills would be more convenient for patients and also easier to manufacture at large scale than other top weight-loss drugs, which require , CEO Dave Ricks said.
The Indianapolis-based drugmaker will acquire Scorpion’s STX-478, a once-daily oral treatment in early trials for breast cancer and other advanced solid tumors.
The 2025 All-Star events, which were moved to Indianapolis in August, include community programs, entertainment and on-court activities such a skills competition and three-point contest.
The company expects fourth-quarter revenue to be about $13.5 billion.
The measure would require a utility or large private-sector project leader to obtain an approval permit before carrying out a project where significant amounts of water are moved from one water basin in the state to another.
Many of Indiana’s largest law firms find it imperative to offer government lobbying for their clients in order to provide a full line of services, especially true in Indianapolis, home to all of state government and the Legislature.
The living-history museum in Fishers is making plans for a larger exhibit that is expected to open in 2029 and better tell the story of the people also known as the Delaware.
The research is the first to attempt to comprehensively investigate the impact—both good and bad—of the GLP-1 weight-loss drugs on the human body.
AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially helping Eli Lilly and Co. and other companies develop new medicines more quickly.
The state has for several years been moving toward competitive integrated employment, in which people with disabilities work alongside non-disabled people for the same wages and benefits.
Through House Bill 1489, the state would establish a trade commission with Ireland to strengthen its business relationship with the country and exchange ideas on policy, economic development and infrastructure.